Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
VTS
|
Brian Cree
President |
SELL
Open market or private sale
|
Direct | 18,000 Reduced 3.72% |
$347,939
$19.33 p/Share
|
Jan 20
2026 |
|
HIMS
|
Oluyemi Okupe
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 9,067 Reduced 9.01% |
$275,092
$30.34 p/Share
|
Jan 20
2026 |
|
APLS
|
Pascal Deschatelets
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 909 Reduced 0.08% |
$17,989
$19.79 p/Share
|
Jan 20
2026 |
|
APLS
|
Mark Jeffrey De Long
Chief Business & Strat Officer |
SELL
Open market or private sale
|
Direct | 1,334 Reduced 1.61% |
$26,399
$19.79 p/Share
|
Jan 20
2026 |
|
APLS
|
James George Chopas
VP/Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 726 Reduced 1.38% |
$14,367
$19.79 p/Share
|
Jan 20
2026 |
|
APLS
|
Caroline Baumal
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 1,882 Reduced 2.06% |
$37,244
$19.79 p/Share
|
Jan 20
2026 |
|
IDCC
|
Lawrence Liren Chen
President and CEO |
SELL
Open market or private sale
|
Direct | 2,975 Reduced 1.8% |
$903,715
$303.77 p/Share
|
Jan 20
2026 |
|
EQH
|
Mark Pearson
President and CEO |
SELL
Open market or private sale
|
Direct | 39,700 Reduced 5.73% |
$1,843,668
$46.44 p/Share
|
Jan 20
2026 |
|
APLS
|
Timothy Eugene Sullivan
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 2,892 Reduced 2.7% |
$57,232
$19.79 p/Share
|
Jan 20
2026 |
|
APLS
|
Nur Nicholson
Chief Technical Officer |
SELL
Open market or private sale
|
Direct | 2,203 Reduced 2.72% |
$43,597
$19.79 p/Share
|
Jan 20
2026 |
|
APLS
|
Cedric Francois
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 8,182 Reduced 2.55% |
$161,921
$19.79 p/Share
|
Jan 20
2026 |
|
BEAM
|
Bethany J Cavanagh
SVP, Finance and Treasurer |
SELL
Open market or private sale
|
Direct | 3,034 Reduced 6.89% |
$91,384
$30.12 p/Share
|
Jan 20
2026 |
|
IRMD
|
Roger E. Susi
CEO, PRESIDENT, CHAIRMAN |
SELL
Open market or private sale
|
Indirect | 5,000 Reduced 0.0% |
$509,600
$101.92 p/Share
|
Jan 20
2026 |
|
MIRM
|
Joanne Quan
CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct | 6,911 Reduced 37.94% |
$623,855
$90.27 p/Share
|
Jan 20
2026 |
|
ACN
|
Katherine Lee Clifford
Chief Leadership & HR Officer |
SELL
Open market or private sale
|
Direct | 681 Reduced 9.12% |
$190,775
$280.14 p/Share
|
Jan 20
2026 |
|
TVTX
|
Elizabeth E Reed
Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 9.97% |
$273,400
$27.34 p/Share
|
Jan 20
2026 |
|
APLS
|
David O. Watson
General Counsel |
SELL
Open market or private sale
|
Direct | 2,475 Reduced 2.5% |
$48,980
$19.79 p/Share
|
Jan 20
2026 |
|
VICR
|
Andrew D'Amico
Director |
SELL
Open market or private sale
|
Direct | 200 Reduced 100.0% |
$31,000
$155.0 p/Share
|
Jan 20
2026 |
|
IRIX
|
Romeo R Dizon
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 2,100 Added 2.09% |
$3,150
$1.5 p/Share
|
Jan 20
2026 |
|
JBHT
|
Nicholas Hobbs
EVP and COO |
SELL
Open market or private sale
|
Direct | 3,038 Reduced 3.25% |
$613,584
$201.97 p/Share
|
Jan 20
2026 |
|
SYNA
|
Rahul G. Patel
Director |
SELL
Open market or private sale
|
Direct | 2,281 Reduced 1.97% |
$198,743
$87.13 p/Share
|
Jan 20
2026 |
|
RCG
|
Murray Stahl
President/Co-Portfolio Manager |
BUY
Open market or private purchase
|
Indirect | 774 Added 0.0% |
$2,082
$2.69 p/Share
|
Jan 20
2026 |
|
RCG
|
Murray Stahl
President/Co-Portfolio Manager |
BUY
Open market or private purchase
|
Direct | 360 Added 0.25% |
$968
$2.69 p/Share
|
Jan 20
2026 |
|
TPL
|
Horizon Kinetics Asset Management LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 1 Added 0.0% |
$334
$334.13 p/Share
|
Jan 20
2026 |
|
COSM
|
Grigorios Siokas
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 353,321 Added 4.18% |
$176,660
$0.5 p/Share
|
Jan 20
2026 |
|
MLYS
|
David Malcom Rodman
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 416 Reduced 0.82% |
$13,353
$32.1 p/Share
|
Jan 20
2026 |
|
NRIX
|
Christine Ring
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 3,760 Reduced 6.88% |
$69,259
$18.42 p/Share
|
Jan 20
2026 |
|
ACLX
|
David Charles Lubner |
SELL
Open market or private sale
|
Direct | 6,000 Reduced 21.69% |
$450,000
$75.0 p/Share
|
Jan 20
2026 |
|
SRZN
|
Column Group Iii Gp, LP |
BUY
Open market or private purchase
|
Indirect | 18,052 Added 0.0% |
$353,819
$19.6 p/Share
|
Jan 20
2026 |
|
SRZN
|
Tim Kutzkey |
BUY
Open market or private purchase
|
Indirect | 18,052 Added 0.0% |
$353,819
$19.6 p/Share
|
Jan 20
2026 |
|
AURA
|
Pinos Elisabet De Los |
SELL
Open market or private sale
|
Direct | 16,928 Reduced 3.57% |
$82,270
$4.86 p/Share
|
Jan 20
2026 |
|
AURA
|
Amy Elazzouzi
Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct | 1,581 Reduced 1.85% |
$7,683
$4.86 p/Share
|
Jan 20
2026 |
|
MYPS
|
Scott Edward Peterson
Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect | 11,593 Added 0.0% |
-
|
Jan 20
2026 |
|
GME
|
Alain Attal
Director |
BUY
Open market or private purchase
|
Direct | 12,000 Added 2.01% |
$250,799
$20.9 p/Share
|
Jan 20
2026 |
|
KYMR
|
Pamela Esposito |
SELL
Open market or private sale
|
Direct | 5,500 Reduced 100.0% |
$372,515
$67.73 p/Share
|
Jan 20
2026 |
|
MDGL
|
Shannon T Kelley
General Counsel |
SELL
Open market or private sale
|
Direct | 692 Reduced 7.54% |
$343,287
$496.08 p/Share
|
Jan 20
2026 |
|
MDGL
|
Rebecca Taub
Director |
SELL
Open market or private sale
|
Direct | 2,238 Reduced 0.49% |
$1,098,343
$490.77 p/Share
|
Jan 20
2026 |
|
CLOV
|
Jamie L. Reynoso
CEO, Medicare Advantage |
SELL
Open market or private sale
|
Direct | 4,597 Reduced 0.17% |
$11,860
$2.58 p/Share
|
Jan 20
2026 |
|
KCAC-UN
|
Kang Sun
Director |
SELL
Open market or private sale
|
Direct | 43,185 Reduced 2.98% |
$476,330
$11.03 p/Share
|
Jan 20
2026 |
|
YELP
|
Jeremy Stoppelman
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 3.81% |
$842,100
$28.07 p/Share
|
Jan 20
2026 |
|
DLPN
|
William Iv O'Dowd
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 3,100 Added 0.72% |
$4,991
$1.61 p/Share
|
Jan 20
2026 |
|
LNW
|
Fine Capital Partners, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 19,729 Reduced 0.0% |
$2,388,195
$121.05 p/Share
|
Jan 19
2026 |
|
STRW
|
Greg Curtis Flamion
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 1,431 Added 29.91% |
$18,746
$13.1 p/Share
|
Jan 16
2026 |
|
STRW
|
Jeffrey Bajtner
Chief Investment Officer |
BUY
Open market or private purchase
|
Direct | 1,431 Added 28.42% |
$18,746
$13.1 p/Share
|
Jan 16
2026 |
|
IVFH
|
Robert William Bennett |
SELL
Open market or private sale
|
Direct | 22,500 Reduced 5.25% |
$9,675
$0.43 p/Share
|
Jan 16
2026 |
|
IVFH
|
Robert William Bennett |
SELL
Open market or private sale
|
Indirect | 19,410 Reduced 0.0% |
$8,346
$0.43 p/Share
|
Jan 16
2026 |
|
RMCF
|
Global Value Investment Corp. |
BUY
Open market or private purchase
|
Indirect | 11,300 Added 0.0% |
$22,374
$1.98 p/Share
|
Jan 16
2026 |
|
RMCF
|
Jeffrey Richart Geygan
Interim CEO |
BUY
Open market or private purchase
|
Indirect | 11,300 Added 0.0% |
$22,374
$1.98 p/Share
|
Jan 16
2026 |
|
MIGI
|
Endeavor Blockchain, LLC |
BUY
Open market or private purchase
|
Direct | 140,000 Added 9.09% |
$655,200
$4.68 p/Share
|
Jan 16
2026 |
|
IBRX
|
Christobel Selecky
Director |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 100.0% |
$250,000
$5.0 p/Share
|
Jan 16
2026 |